KORU Medical Systems, Inc. (KRMD)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $160.49M
Last updated: Nov 17, 2026 at 11:04 AM ET
KORU Medical Systems, Inc. (KRMD) P/E Ratio & Valuation History
KORU Medical Systems (KRMD) trades at 163.3x trailing earnings and 3.7x sales. Its P/S of 3.7x is below its 5-year median of 4.4x. Its forward P/E is 92.6x. The median P/E across 5 similar companies is 21.2x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 76.3% higher over the next year.
| Multiple | Value |
|---|---|
| P/E (trailing) | 163.3x |
| Forward P/E | 92.6x |
| Price to sales | 3.7x |
| PEG | N/A |
| FCF yield | -0.5% |
Historical Medians
Against its 10-year medians, its P/S is 14.0% below 4.3x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 3.7x | 4.4x | 4.3x |
| P/B | N/A | 5.9x | 6.1x |
Valuation History
Over the 4 of the 10 year ends shown that have a P/E, its P/E ranged from 27.5x in 2018 to 200.7x in 2020. 2020 was the highest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $5.81 | N/A | 6.5x | 15.7x |
| 2024 | $3.85 | N/A | 5.2x | 10.5x |
| 2023 | $2.46 | N/A | 3.9x | 5.5x |
| 2022 | $3.57 | N/A | 5.8x | 5.2x |
| 2021 | $3.00 | N/A | 5.7x | 3.7x |
| 2020 | $6.02 | 200.7x | 10.4x | 7.3x |
| 2019 | $6.53 | 65.3x | 11.1x | 23.1x |
| 2018 | $1.65 | 27.5x | 3.6x | 7.2x |
| 2017 | $1.25 | N/A | 3.1x | 6.3x |
| 2016 | $0.50 | 96.2x | 1.5x | 2.8x |
Frequently Asked Questions About KRMD
What is KRMD's forward P/E ratio?
KORU Medical Systems has a forward P/E ratio of 92.6x.
Is KRMD stock overvalued?
Its P/E of 163.3x compares with a median of 21.2x across 5 similar companies.
What is KRMD's price to sales ratio?
KORU Medical Systems has a price to sales ratio of 3.7x.
KRMD pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors